New Delhi, June 16: In a significant regulatory change aimed at strengthening public health safeguards, the Central government has prohibited the over-the-counter sale of syrup-based medicines, including cough syrups, without a valid prescription from a registered medical practitioner.
The decision follows an amendment to the Drugs Rules, 1945 through the Drugs (Fifth Amendment) Rules, 2026, which has tightened oversight of syrup formulations and brought their sale under stricter regulatory control.
The amendment removes the word “syrups” from the list of exempted drugs under Schedule K of the Drugs Rules, thereby ending certain relaxations that previously applied to the sale and distribution of such medicines.
With the new provisions coming into effect, consumers seeking to purchase cough syrups and similar syrup-based medications will now be required to present a doctor’s prescription. The medicines can only be dispensed through licensed pharmacies operating in accordance with the Drugs and Cosmetics Act, 1940, and the Drugs Rules, 1945.
The move marks a notable shift in the regulation of commonly used medicines and is intended to strengthen monitoring of products that were previously available under more relaxed conditions in certain areas.
Schedule K of the Drugs Rules contains categories of medicines that are exempt from specific provisions relating to manufacture, sale and distribution, subject to prescribed conditions. These exemptions were originally introduced to improve access to medicines and reduce compliance requirements in defined situations.
One of the provisions allowed cough syrups to be sold in villages with populations below 1,000 without adherence to certain retail licensing requirements. Following the amendment, that exemption has been withdrawn.
As a result, cough syrups can no longer be sold through unlicensed channels, even in remote villages where such exemptions had previously applied. Their sale and dispensing must now be carried out exclusively through duly licensed pharmacies.
According to the government, the amendment has been introduced to align the regulatory framework with current public health and safety requirements. Authorities believe that stricter oversight will help ensure responsible distribution and use of syrup formulations while improving compliance with national drug regulations.
The Health Ministry stated that the revised rules are aimed at enhancing regulatory supervision of syrup-based medicines and strengthening safeguards surrounding their availability and distribution.
Manufacturers, distributors and retailers have been advised to ensure strict compliance with all applicable provisions under the Drugs and Cosmetics Act and related rules. The government has indicated that adherence to licensing requirements will be essential for all entities involved in the supply chain of syrup formulations.
The decision is expected to impact the sale of commonly used cough and cold medications that have traditionally been available without extensive purchase restrictions in many parts of the country.
Public health experts have long advocated stronger monitoring of certain medicinal formulations to prevent misuse, inappropriate self-medication and distribution through unregulated channels. The latest amendment is expected to contribute to greater accountability within the pharmaceutical supply chain while ensuring that medicines are dispensed under appropriate medical guidance.
The requirement for a doctor’s prescription may also encourage more professional medical consultation before the use of cough and related medications, particularly in cases involving prolonged symptoms or underlying health conditions.
The government has maintained that the objective of the amendment is not to restrict access to treatment but to ensure that medicines are distributed through regulated systems that prioritize patient safety and compliance with pharmaceutical standards.
With the amendment now in place, licensed pharmacies will become the sole authorized outlets for dispensing cough syrups and other covered syrup-based medicines, marking a significant change in how these products are accessed by consumers across the country.
